Key result
Repaired Tetralogy of Fallot was associated with 49 significantly altered circulating miRNAs compared to healthy controls, with lower levels of miR-421, miR-1233-3p, and miR-625-5p indicating symptomatic right heart failure.
Why the study?
Are specific circulating microRNAs altered in patients with repaired Tetralogy of Fallot, and can they differentiate those with and without right heart failure?
Case-Control (n=52)
No
Are specific circulating microRNAs altered in patients with repaired Tetralogy of Fallot, and can they differentiate those with and without right heart failure?
p-value: p=<0.05
Circulating microRNAs, specifically miR-421, miR-1233-3p, and miR-625-5p, are altered in patients with repaired Tetralogy of Fallot and may serve as biomarkers for right heart failure progression.
Authors
No takes yet. Share an insight, caveat, or question.
Supports miRNA biomarker research in repaired TOF; hypothesis-generating and requires prospective validation before clinical use.
Abu‐Halima et al. (2017) conducted a case-control in Repaired Tetralogy of Fallot (n=52). Repaired Tetralogy of Fallot vs. Healthy controls was evaluated on Significantly altered circulating miRNAs (>2.0-fold change) (p=<0.05). Repaired Tetralogy of Fallot was associated with 49 significantly altered circulating miRNAs compared to healthy controls, with lower levels of miR-421, miR-1233-3p, and miR-625-5p indicating symptomatic right heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: